{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:02:27Z","timestamp":1791928947349,"version":"4.3.4"},"reference-count":67,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2020-01665"],"award-info":[{"award-number":["2020-01665"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tuberous sclerosis complex (TSC) is an inherited multi-system neurocutaneous disorder where patients often present with neurodevelopmental manifestations such as epilepsy and TSC-associated neuropsychiatric disorder (TAND) that includes autism spectrum disorder (ASD). TSC is caused by inactivating mutations in TSC1 or TSC2 tumour suppressor genes, with encoded proteins hamartin (TSC1) and tuberin (TSC2) forming a functional complex inhibiting mechanistic target of rapamycin complex 1 (mTORC1) signalling. This has led to treatment with allosteric mTORC1 inhibitor rapamycin analogues (\u2018rapalogs\u2019) for TSC tumours; however, rapalogs are ineffective for treating neurodevelopmental manifestations. mTORC1 signalling controls protein synthesis by regulating formation of the eukryotic initiation factor (eIF) 4F complex, with further modulation by MAP kinase-interacting serine\/threonine protein kinases 1 and 2 (MNK1\/2) via phosphorylation of the eIF4F subunit eIF4E. While both these pathways modulate translation, comparing their impact on transcriptome-wide mRNA translation, as well as effects of inhibiting these pathways in TSC has not been explored.<\/jats:p>\n                  <jats:p>Employing CRISPR-modified, isogenic neural progenitor cells (NPCs) derived from a female TSC2 patient, we have examined alterations in early neurodevelopmental phenotypes including proliferation and neurite outgrowth, as well as the ability of the bi-steric mTORC1-specific inhibitor RMC-6272 to rescue these phenotypes. Further, we utilized polysome profiling to examine transcriptome-wide changes in mRNA translation upon TSC2 loss and tested effects of treatment with RMC-6272 or the MNK1\/2-specific inhibitor eFT-508.<\/jats:p>\n                  <jats:p>Our results reveal that altered early neurodevelopmental phenotypes can be rescued upon treatment with RMC-6272, but not rapamycin. We also discovered dysregulated mRNA translation in TSC2-Null NPCs, which significantly overlaps with the translatome from TSC1-Null NPCs. Interestingly, numerous non-monogenic ASD-, neurodevelopmental disorder (NDD)- and epilepsy-associated genes identified in patients harbouring putative loss-of-function mutations, were translationally suppressed in TSC2-Null NPCs. Importantly, translation of these ASD- and NDD-associated genes was reversed upon inhibition of either mTORC1 or MNK1\/2 signalling using RMC-6272 or eFT-508, respectively.<\/jats:p>\n                  <jats:p>This study establishes the importance of mTORC1-eIF4F- and MNK-eIF4E-sensitive mRNA translation in TAND, ASD and other neurodevelopmental disorders laying the groundwork for evaluating drugs in clinical development that target these pathways as a treatment strategy for these disorders.<\/jats:p>","DOI":"10.1093\/brain\/awaf081","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T07:50:15Z","timestamp":1740729015000},"page":"2935-2950","source":"Crossref","is-referenced-by-count":3,"title":["TSC2 loss in neural progenitor cells suppresses mRNA translation of neurodevelopmental genes"],"prefix":"10.1093","volume":"148","author":[{"given":"Pauline","family":"Martin","sequence":"first","affiliation":[{"name":"Department of Neurology, Center for Genomic Medicine, Massachusetts General Hospital , Boston, MA 02114 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof J","family":"Szkop","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institute , 171 77 Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Robert","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Goodman Cancer Research Institute, McGill University , Montreal PQ H3G1Y6 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srirupa","family":"Bhattacharyya","sequence":"additional","affiliation":[{"name":"Department of Neurology, Center for Genomic Medicine, Massachusetts General Hospital , Boston, MA 02114 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta L","family":"Beauchamp","sequence":"additional","affiliation":[{"name":"Department of Neurology, Center for Genomic Medicine, Massachusetts General Hospital , Boston, MA 02114 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Brenner","sequence":"additional","affiliation":[{"name":"Department of Neurology, Center for Genomic Medicine, Massachusetts General Hospital , Boston, MA 02114 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas E","family":"Redmond","sequence":"additional","affiliation":[{"name":"Department of Neurology, Center for Genomic Medicine, Massachusetts General Hospital , Boston, MA 02114 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidong","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Goodman Cancer Research Institute, McGill University , Montreal PQ H3G1Y6 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkan","family":"Erdin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Center for Genomic Medicine, Massachusetts General Hospital , Boston, MA 02114 ,","place":["USA"]},{"name":"Program in Medical and Population Genetics, Broad Institute of Harvard and MIT , Cambridge, MA 02142 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Larsson","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institute , 171 77 Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4966-5268","authenticated-orcid":false,"given":"Vijaya","family":"Ramesh","sequence":"additional","affiliation":[{"name":"Department of Neurology, Center for Genomic Medicine, Massachusetts General Hospital , Boston, MA 02114 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"key":"2025080112525093500_awaf081-B1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s11689-023-09500-1","article-title":"International consensus recommendations for the identification and treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)","volume":"15","author":"de Vries","year":"2023","journal-title":"J Neurodev Disord."},{"key":"2025080112525093500_awaf081-B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2016.35","article-title":"Tuberous sclerosis complex","volume":"2","author":"Henske","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2025080112525093500_awaf081-B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2016.03.015","article-title":"Advances and future directions for tuberous sclerosis complex research: Recommendations from the 2015 strategic planning conference","volume":"60","author":"Sahin","year":"2016","journal-title":"Pediatr Neurol"},{"key":"2025080112525093500_awaf081-B4","doi-asserted-by":"crossref","first-page":"8313","DOI":"10.1074\/jbc.C500451200","article-title":"TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase","volume":"281","author":"Chong-Kopera","year":"2006","journal-title":"J Biol Chem"},{"key":"2025080112525093500_awaf081-B5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20080281","article-title":"The TSC1-TSC2 complex: A molecular switchboard controlling cell growth","volume":"412","author":"Huang","year":"2008","journal-title":"Biochem J"},{"key":"2025080112525093500_awaf081-B6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"key":"2025080112525093500_awaf081-B7","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1158\/1078-0432.CCR-11-0445","article-title":"Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: A phase 2 trial","volume":"17","author":"Davies","year":"2011","journal-title":"Clin Cancer Res."},{"key":"2025080112525093500_awaf081-B8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.pediatrneurol.2013.12.002","article-title":"Mechanism-based treatment in tuberous sclerosis complex","volume":"50","author":"Julich","year":"2014","journal-title":"Pediatr Neurol."},{"key":"2025080112525093500_awaf081-B9","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N Engl J Med."},{"key":"2025080112525093500_awaf081-B10","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2147\/TCRM.S145630","article-title":"Everolimus for the treatment of refractory seizures associated with tuberous sclerosis complex (TSC): Current perspectives","volume":"15","author":"Overwater","year":"2019","journal-title":"Ther Clin Risk Manag"},{"key":"2025080112525093500_awaf081-B11","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/acn3.494","article-title":"Everolimus for treatment of tuberous sclerosis complex-associated neuropsychiatric disorders","volume":"4","author":"Krueger","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"key":"2025080112525093500_awaf081-B12","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1212\/WNL.0000000000007749","article-title":"A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex","volume":"93","author":"Overwater","year":"2019","journal-title":"Neurology."},{"key":"2025080112525093500_awaf081-B13","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41580-021-00386-2","article-title":"Translational control of stem cell function","volume":"22","author":"Saba","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2025080112525093500_awaf081-B14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1042\/BST20160072","article-title":"The molecular basis of mTORC1-regulated translation","volume":"45","author":"Thoreen","year":"2017","journal-title":"Biochem Soc Trans"},{"key":"2025080112525093500_awaf081-B15","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1080\/15476286.2017.1290041","article-title":"mTOR-sensitive translation: Cleared fog reveals more trees","volume":"14","author":"Masvidal","year":"2017","journal-title":"RNA Biol"},{"key":"2025080112525093500_awaf081-B16","doi-asserted-by":"crossref","first-page":"11127","DOI":"10.1038\/ncomms11127","article-title":"mTORC1 and CK2 coordinate ternary and eIF4F complex assembly","volume":"7","author":"Gandin","year":"2016","journal-title":"Nat Commun"},{"key":"2025080112525093500_awaf081-B17","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.tibs.2016.07.008","article-title":"Tuning specific translation in cancer metastasis and synaptic memory: Control at the MNK-eIF4E axis","volume":"41","author":"Bramham","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"2025080112525093500_awaf081-B18","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/s41589-022-01047-x","article-title":"MNK2 deficiency potentiates beta-cell regeneration via translational regulation","volume":"18","author":"Karampelias","year":"2022","journal-title":"Nat Chem Biol"},{"key":"2025080112525093500_awaf081-B19","doi-asserted-by":"crossref","first-page":"17414","DOI":"10.1073\/pnas.0809136105","article-title":"Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation. Research support, N.I.H., extramural","volume":"105","author":"Choo","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2025080112525093500_awaf081-B20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1158\/1078-0432.CCR-17-0042","article-title":"Inhibiting 4EBP1 in glioblastoma","volume":"24","author":"Fan","year":"2018","journal-title":"Clin Cancer Res"},{"key":"2025080112525093500_awaf081-B21","doi-asserted-by":"crossref","first-page":"8977","DOI":"10.1073\/pnas.1201689109","article-title":"Distinct perturbation of the translatome by the antidiabetic drug metformin","volume":"109","author":"Larsson","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"2025080112525093500_awaf081-B22","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nature17963","article-title":"Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor","volume":"534","author":"Rodrik-Outmezguine","year":"2016","journal-title":"Nature"},{"key":"2025080112525093500_awaf081-B23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1021\/acs.jmedchem.2c01658","article-title":"Discovery of RMC-5552, a selective bi-steric inhibitor of mTORC1, for the treatment of mTORC1-activated tumors","volume":"66","author":"Burnett","year":"2023","journal-title":"J Med Chem"},{"key":"2025080112525093500_awaf081-B24","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/s41589-021-00813-7","article-title":"Selective inhibitors of mTORC1 activate 4EBP1 and suppress tumor growth","volume":"17","author":"Lee","year":"2021","journal-title":"Nat Chem Biol"},{"key":"2025080112525093500_awaf081-B25","first-page":"vdae024","article-title":"Preclinical evaluation of the third-generation, bi-steric mechanistic target of rapamycin complex 1-selective inhibitor RMC-6272 in NF2-deficient models","volume":"6","author":"Bhattacharyya","year":"2024","journal-title":"Neurooncol Adv"},{"key":"2025080112525093500_awaf081-B26","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1021\/acs.jmedchem.7b01795","article-title":"Structure-based design of pyridone-aminal eFT508 targeting dysregulated translation by selective mitogen-activated protein kinase interacting kinases 1 and 2 (MNK1\/2) inhibition","volume":"61","author":"Reich","year":"2018","journal-title":"J Med Chem"},{"key":"2025080112525093500_awaf081-B27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13229-023-00572-3","article-title":"Translatome analysis of tuberous sclerosis complex 1 patient-derived neural progenitor cells reveals rapamycin-dependent and independent alterations","volume":"14","author":"Aksoylu","year":"2023","journal-title":"Mol Autism"},{"key":"2025080112525093500_awaf081-B28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nbt.3070","article-title":"A comparison of non-integrating reprogramming methods","volume":"33","author":"Schlaeger","year":"2015","journal-title":"Nat Biotechnol"},{"key":"2025080112525093500_awaf081-B29","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","article-title":"Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA","volume":"7","author":"Warren","year":"2010","journal-title":"Cell Stem Cell"},{"key":"2025080112525093500_awaf081-B30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13229-019-0311-3","article-title":"TSC patient-derived isogenic neural progenitor cells reveal altered early neurodevelopmental phenotypes and rapamycin-induced MNK-eIF4E signaling","volume":"11","author":"Martin","year":"2020","journal-title":"Mol Autism"},{"key":"2025080112525093500_awaf081-B31","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41593-018-0334-7","article-title":"Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning","volume":"22","author":"Sellgren","year":"2019","journal-title":"Nat Neurosci"},{"key":"2025080112525093500_awaf081-B32","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/1087057110382894","article-title":"HCA-vision: Automated neurite outgrowth analysis","volume":"15","author":"Wang","year":"2010","journal-title":"J Biomol Screen"},{"key":"2025080112525093500_awaf081-B33","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1093\/nar\/gkz223","article-title":"Generally applicable transcriptome-wide analysis of translation using anota2seq","volume":"47","author":"Oertlin","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2025080112525093500_awaf081-B34","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2025080112525093500_awaf081-B35","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41588-022-01104-0","article-title":"Rare coding variation provides insight into the genetic architecture and phenotypic context of autism","volume":"54","author":"Fu","year":"2022","journal-title":"Nat Genet"},{"key":"2025080112525093500_awaf081-B36","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1038\/s41593-024-01747-8","article-title":"Exome sequencing of 20,979 individulas with epilespsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes","volume":"27","author":"Epi25 Collaborative","year":"2024","journal-title":"Nat Neurosci."},{"key":"2025080112525093500_awaf081-B37","doi-asserted-by":"crossref","first-page":"6814","DOI":"10.1158\/0008-5472.CAN-07-0752","article-title":"Eukaryotic translation initiation factor 4E induced progression of primary human mammary epithelial cells along the cancer pathway is associated with targeted translational deregulation of oncogenic drivers and inhibitors","volume":"67","author":"Larsson","year":"2007","journal-title":"Cancer Res"},{"key":"2025080112525093500_awaf081-B38","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/321972","article-title":"Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions","volume":"69","author":"Niida","year":"2001","journal-title":"Am J Hum Genet"},{"key":"2025080112525093500_awaf081-B39","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/s41591-018-0139-y","article-title":"Genetically engineered human cortical spheroid models of tuberous sclerosis","volume":"24","author":"Blair","year":"2018","journal-title":"Nat Med"},{"key":"2025080112525093500_awaf081-B40","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.celrep.2016.02.090","article-title":"mTORC1 inhibition corrects neurodevelopmental and synaptic alterations in a human stem cell model of tuberous sclerosis","volume":"15","author":"Costa","year":"2016","journal-title":"Cell Rep"},{"key":"2025080112525093500_awaf081-B41","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1038\/s41380-018-0018-4","article-title":"Purkinje cells derived from TSC patients display hypoexcitability and synaptic deficits associated with reduced FMRP levels and reversed by rapamycin","volume":"23","author":"Sundberg","year":"2018","journal-title":"Mol Psychiatry"},{"key":"2025080112525093500_awaf081-B42","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mcn.2018.08.004","article-title":"Neural progenitors derived from tuberous sclerosis complex patients exhibit attenuated PI3K\/AKT signaling and delayed neuronal differentiation","volume":"92","author":"Zucco","year":"2018","journal-title":"Mol Cell Neurosci"},{"key":"2025080112525093500_awaf081-B43","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1126\/science.1187532","article-title":"mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs","volume":"328","author":"Dowling","year":"2010","journal-title":"Science"},{"key":"2025080112525093500_awaf081-B44","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-0716-1920-9_15","article-title":"Anota2seq analysis for transcriptome-wide studies of mRNA translation","volume":"2418","author":"Oertlin","year":"2022","journal-title":"Methods Mol Biol"},{"key":"2025080112525093500_awaf081-B45","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1164\/rccm.201801-0080OC","article-title":"Distinct cancer-promoting stromal gene expression depending on lung function","volume":"200","author":"Sandri","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2025080112525093500_awaf081-B46","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s41568-023-00567-5","article-title":"The role of eIF4F-driven mRNA translation in regulating the tumour microenvironment","volume":"23","author":"Bartish","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"2025080112525093500_awaf081-B47","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41580-018-0034-x","article-title":"Translation deregulation in human disease","volume":"19","author":"Tahmasebi","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2025080112525093500_awaf081-B48","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1101\/gr.197566.115","article-title":"nanoCAGE reveals 5\u2019 UTR features that define specific modes of translation of functionally related MTOR-sensitive mRNAs","volume":"26","author":"Gandin","year":"2016","journal-title":"Genome Res"},{"key":"2025080112525093500_awaf081-B49","doi-asserted-by":"crossref","first-page":"e500577","DOI":"10.1128\/MCB.00577-16","article-title":"mTORC1 and \u22122 coordinate transcriptional and translational reprogramming in resistance to DNA damage and replicative stress in breast cancer cells","volume":"37","author":"Silvera","year":"2017","journal-title":"Mol Cell Biol"},{"key":"2025080112525093500_awaf081-B50","doi-asserted-by":"crossref","first-page":"6979","DOI":"10.1038\/s41467-021-27087-w","article-title":"A DAP5\/eIF3d alternate mRNA translation mechanism promotes differentiation and immune suppression by human regulatory T cells","volume":"12","author":"Volta","year":"2021","journal-title":"Nat Commun"},{"key":"2025080112525093500_awaf081-B51","doi-asserted-by":"crossref","first-page":"e242","DOI":"10.1371\/journal.pone.0000242","article-title":"Epigenetic activation of a subset of mRNAs by eIF4E explains its effects on cell proliferation","volume":"2","author":"Mamane","year":"2007","journal-title":"PLoS One"},{"key":"2025080112525093500_awaf081-B52","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1042\/BJ20141066","article-title":"The MAP kinase-interacting kinases regulate cell migration, vimentin expression and eIF4E\/CYFIP1 binding","volume":"467","author":"Beggs","year":"2015","journal-title":"Biochem J"},{"key":"2025080112525093500_awaf081-B53","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/onc.2014.146","article-title":"Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3","volume":"34","author":"Robichaud","year":"2015","journal-title":"Oncogene"},{"key":"2025080112525093500_awaf081-B54","first-page":"1","article-title":"Convergent coexpression of autism-associated genes suggests some novel risk genes may not be detectable in large-scale genetic studies","volume":"3","author":"Liao","year":"2023","journal-title":"Cell Genom"},{"key":"2025080112525093500_awaf081-B55","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature11737","article-title":"FMRP targets distinct mRNA sequence elements to regulate protein expression","volume":"492","author":"Ascano","year":"2012","journal-title":"Nature"},{"key":"2025080112525093500_awaf081-B56","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2011.06.013","article-title":"FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism","volume":"146","author":"Darnell","year":"2011","journal-title":"Cell"},{"key":"2025080112525093500_awaf081-B57","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1016\/j.celrep.2019.02.086","article-title":"Widespread alterations in translation elongation in the brain of juvenile Fmr1 knockout mice","volume":"26","author":"Das Sharma","year":"2019","journal-title":"Cell Rep"},{"key":"2025080112525093500_awaf081-B58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/genetics\/iyac094","article-title":"FMRP-dependent production of large dosage-sensitive proteins is highly conserved","volume":"221","author":"Flanagan","year":"2022","journal-title":"Genetics"},{"key":"2025080112525093500_awaf081-B59","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41583-021-00432-0","article-title":"The molecular biology of FMRP: New insights into fragile X syndrome","volume":"22","author":"Richter","year":"2021","journal-title":"Nat Rev Neurosci"},{"key":"2025080112525093500_awaf081-B60","doi-asserted-by":"crossref","first-page":"e46919","DOI":"10.7554\/eLife.46919","article-title":"FMRP has a cell-type-specific role in CA1 pyramidal neurons to regulate autism-related transcripts and circadian memory","volume":"8","author":"Sawicka","year":"2019","journal-title":"Elife"},{"key":"2025080112525093500_awaf081-B61","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.pnpbp.2017.12.013","article-title":"The chromatin basis of neurodevelopmental disorders: Rethinking dysfunction along the molecular and temporal axes","volume":"84","author":"Gabriele","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2025080112525093500_awaf081-B62","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1007\/s00018-020-03714-5","article-title":"The emerging role of chromatin remodelers in neurodevelopmental disorders: A developmental perspective","volume":"78","author":"Mossink","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"2025080112525093500_awaf081-B63","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.molcel.2017.11.007","article-title":"A unique ISR program determines cellular responses to chronic stress","volume":"68","author":"Guan","year":"2017","journal-title":"Mol Cell"},{"key":"2025080112525093500_awaf081-B64","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.15252\/embr.201642195","article-title":"The integrated stress response","volume":"17","author":"Pakos-Zebrucka","year":"2016","journal-title":"EMBO Rep"},{"key":"2025080112525093500_awaf081-B65","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.expneurol.2014.08.005","article-title":"MicroRNAs: Small molecules with big roles in neurodevelopment and diseases","volume":"268","author":"Sun","year":"2015","journal-title":"Exp Neurol"},{"key":"2025080112525093500_awaf081-B66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms232214493","article-title":"MicroRNA expression profile in TSC cell lines and the impact of mTOR inhibitor","volume":"23","author":"Pawlik","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2025080112525093500_awaf081-B67","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13229-015-0040-1","article-title":"Hypomethylation of miR-142 promoter and upregulation of microRNAs that target the oxytocin receptor gene in the autism prefrontal cortex","volume":"6","author":"Mor","year":"2015","journal-title":"Mol Autism"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awaf081\/62230328\/awaf081.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/148\/8\/2935\/62230328\/awaf081.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/148\/8\/2935\/62230328\/awaf081.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T16:53:13Z","timestamp":1754067193000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/148\/8\/2935\/8050733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":67,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,3,3]]},"published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awaf081","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,3,3]]}}}